Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.430
0.00 (0.00%)
At close: May 8, 2026, 4:00 PM EDT
1.422
-0.008 (-0.53%)
Pre-market: May 11, 2026, 5:52 AM EDT

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
38.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veru Inc.16.89M
Evaxion7.53M
Aligos Therapeutics4.71M
CervoMed4.01M
RenovoRx1.12M
Daré Bioscience1.03M
Hyperion DeFi813.46K
Mereo BioPharma Group500.00K
Revenue Rankings

INMB News

More News